Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
12.27
+0.13 (1.07%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Pediatrix Medical Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -99.07 | -60.41 | 66.34 | 130.96 | -796.49 | Upgrade
|
| Depreciation & Amortization | 32.23 | 36.17 | 35.64 | 32.15 | 28.44 | Upgrade
|
| Loss (Gain) From Sale of Assets | 9.7 | - | - | -7.28 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 178.44 | 148.31 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 20 | - | - | - | Upgrade
|
| Stock-Based Compensation | 11.87 | 12.32 | 16.13 | 18.97 | 39.04 | Upgrade
|
| Other Operating Activities | -4.15 | 1.31 | 32.39 | -37.67 | 830.17 | Upgrade
|
| Change in Accounts Receivable | 10.29 | 26.28 | -5.54 | -72.73 | 37.94 | Upgrade
|
| Change in Accounts Payable | 51.14 | -11.92 | 0.42 | 21.33 | 47.91 | Upgrade
|
| Change in Income Taxes | -5.04 | -21.68 | 18.23 | -2.29 | -6.93 | Upgrade
|
| Change in Other Net Operating Assets | 31.84 | -4.31 | 18.73 | 30.32 | -26.19 | Upgrade
|
| Operating Cash Flow | 206.57 | 137.33 | 166.94 | 76.74 | 204.62 | Upgrade
|
| Operating Cash Flow Growth | 50.43% | -17.74% | 117.55% | -62.50% | -42.80% | Upgrade
|
| Capital Expenditures | -22.02 | -33.33 | -29.71 | -32.25 | -28.79 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 24.73 | - | Upgrade
|
| Cash Acquisitions | -8.17 | -6.67 | -28.17 | -29.93 | -2.23 | Upgrade
|
| Investment in Securities | -12.05 | -8.99 | -0.46 | -18.56 | -28.41 | Upgrade
|
| Other Investing Activities | 6.84 | 0.81 | 1.38 | 2.93 | 874.94 | Upgrade
|
| Investing Cash Flow | -35.41 | -48.18 | -56.95 | -53.07 | 815.51 | Upgrade
|
| Long-Term Debt Issued | 235.5 | 470 | 1,480 | - | 527.5 | Upgrade
|
| Long-Term Debt Repaid | -250.89 | -489.12 | -1,885 | -762.66 | -528.66 | Upgrade
|
| Net Debt Issued (Repaid) | -15.39 | -19.12 | -405.17 | -762.66 | -1.16 | Upgrade
|
| Issuance of Common Stock | 3.64 | 4.91 | 5.4 | 6.85 | 7.01 | Upgrade
|
| Repurchase of Common Stock | -1.7 | -0.92 | -88.51 | -4.72 | -8.49 | Upgrade
|
| Other Financing Activities | -1.03 | -10.59 | 0.73 | 0.41 | -1.51 | Upgrade
|
| Financing Cash Flow | -14.49 | -25.72 | -487.55 | -760.12 | -4.16 | Upgrade
|
| Net Cash Flow | 156.68 | 63.43 | -377.57 | -736.45 | 1,016 | Upgrade
|
| Free Cash Flow | 184.55 | 104 | 137.23 | 44.49 | 175.83 | Upgrade
|
| Free Cash Flow Growth | 77.46% | -24.22% | 208.47% | -74.70% | -48.05% | Upgrade
|
| Free Cash Flow Margin | 9.17% | 5.21% | 6.96% | 2.33% | 10.14% | Upgrade
|
| Free Cash Flow Per Share | 2.21 | 1.26 | 1.63 | 0.52 | 2.11 | Upgrade
|
| Cash Interest Paid | 40 | 42.28 | 116.24 | 86.54 | 110.49 | Upgrade
|
| Cash Income Tax Paid | 4.67 | 30.84 | 26.91 | 54.73 | -27.78 | Upgrade
|
| Levered Free Cash Flow | 173.92 | 69.2 | 136.08 | 61.19 | 205.21 | Upgrade
|
| Unlevered Free Cash Flow | 199.39 | 95.5 | 160.89 | 104.14 | 274.26 | Upgrade
|
| Change in Net Working Capital | -62.51 | 18.32 | -13.84 | 50.81 | -128.11 | Upgrade
|
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.